444 related articles for article (PubMed ID: 15791619)
1. Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy.
Javor ED; Ghany MG; Cochran EK; Oral EA; DePaoli AM; Premkumar A; Kleiner DE; Gorden P
Hepatology; 2005 Apr; 41(4):753-60. PubMed ID: 15791619
[TBL] [Abstract][Full Text] [Related]
2. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
[TBL] [Abstract][Full Text] [Related]
3. The long-term effect of recombinant methionyl human leptin therapy on hyperandrogenism and menstrual function in female and pituitary function in male and female hypoleptinemic lipodystrophic patients.
Musso C; Cochran E; Javor E; Young J; Depaoli AM; Gorden P
Metabolism; 2005 Feb; 54(2):255-63. PubMed ID: 15690321
[TBL] [Abstract][Full Text] [Related]
4. The liver diseases of lipodystrophy: the long-term effect of leptin treatment.
Safar Zadeh E; Lungu AO; Cochran EK; Brown RJ; Ghany MG; Heller T; Kleiner DE; Gorden P
J Hepatol; 2013 Jul; 59(1):131-7. PubMed ID: 23439261
[TBL] [Abstract][Full Text] [Related]
5. Leptin levels in nonalcoholic steatohepatitis and chronic hepatitis C.
Giannini E; Botta F; Cataldi A; Tenconi GL; Ceppa P; Barreca T; Testa R
Hepatogastroenterology; 1999; 46(28):2422-5. PubMed ID: 10522010
[TBL] [Abstract][Full Text] [Related]
6. One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study.
Huang MA; Greenson JK; Chao C; Anderson L; Peterman D; Jacobson J; Emick D; Lok AS; Conjeevaram HS
Am J Gastroenterol; 2005 May; 100(5):1072-81. PubMed ID: 15842581
[TBL] [Abstract][Full Text] [Related]
7. Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity?
Chitturi S; Farrell G; Frost L; Kriketos A; Lin R; Fung C; Liddle C; Samarasinghe D; George J
Hepatology; 2002 Aug; 36(2):403-9. PubMed ID: 12143049
[TBL] [Abstract][Full Text] [Related]
8. Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction.
Richardson MM; Jonsson JR; Powell EE; Brunt EM; Neuschwander-Tetri BA; Bhathal PS; Dixon JB; Weltman MD; Tilg H; Moschen AR; Purdie DM; Demetris AJ; Clouston AD
Gastroenterology; 2007 Jul; 133(1):80-90. PubMed ID: 17631134
[TBL] [Abstract][Full Text] [Related]
9. Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement.
Dixon JB; Bhathal PS; O'Brien PE
Obes Surg; 2006 Oct; 16(10):1278-86. PubMed ID: 17059735
[TBL] [Abstract][Full Text] [Related]
10. Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease.
Hossain N; Afendy A; Stepanova M; Nader F; Srishord M; Rafiq N; Goodman Z; Younossi Z
Clin Gastroenterol Hepatol; 2009 Nov; 7(11):1224-9, 1229.e1-2. PubMed ID: 19559819
[TBL] [Abstract][Full Text] [Related]
11. Does leptin play a role in the pathogenesis of human nonalcoholic steatohepatitis?
Chalasani N; Crabb DW; Cummings OW; Kwo PY; Asghar A; Pandya PK; Considine RV
Am J Gastroenterol; 2003 Dec; 98(12):2771-6. PubMed ID: 14687831
[TBL] [Abstract][Full Text] [Related]
12. Serum leptin levels in patients with nonalcoholic steatohepatitis.
Uygun A; Kadayifci A; Yesilova Z; Erdil A; Yaman H; Saka M; Deveci MS; Bagci S; Gulsen M; Karaeren N; Dagalp K
Am J Gastroenterol; 2000 Dec; 95(12):3584-9. PubMed ID: 11151896
[TBL] [Abstract][Full Text] [Related]
13. MRI findings in nonalcoholic steatohepatitis: correlation with histopathology and clinical staging.
Elias J; Altun E; Zacks S; Armao DM; Woosley JT; Semelka RC
Magn Reson Imaging; 2009 Sep; 27(7):976-87. PubMed ID: 19356874
[TBL] [Abstract][Full Text] [Related]
14. A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis.
Promrat K; Lutchman G; Uwaifo GI; Freedman RJ; Soza A; Heller T; Doo E; Ghany M; Premkumar A; Park Y; Liang TJ; Yanovski JA; Kleiner DE; Hoofnagle JH
Hepatology; 2004 Jan; 39(1):188-96. PubMed ID: 14752837
[TBL] [Abstract][Full Text] [Related]
15. Duodenal switch has no detrimental effects on hepatic function and improves hepatic steatohepatitis after 6 months.
Keshishian A; Zahriya K; Willes EB
Obes Surg; 2005; 15(10):1418-23. PubMed ID: 16354521
[TBL] [Abstract][Full Text] [Related]
16. [Relationship between the severity of liver damage and the serum leptin level for nonalcoholic fatty liver disease].
Kim KO; Park SH; Park CH; Han TH; Yoo KS; Kim JH; Lee MS; Kim DJ; Park CK; Cho HD
Korean J Hepatol; 2005 Mar; 11(1):51-8. PubMed ID: 15788885
[TBL] [Abstract][Full Text] [Related]
17. Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study.
Laurin J; Lindor KD; Crippin JS; Gossard A; Gores GJ; Ludwig J; Rakela J; McGill DB
Hepatology; 1996 Jun; 23(6):1464-7. PubMed ID: 8675165
[TBL] [Abstract][Full Text] [Related]
18. Nonalcoholic steatohepatitis: cirrhosis, hepatocellular carcinoma, and burnt-out NASH.
Yoshioka Y; Hashimoto E; Yatsuji S; Kaneda H; Taniai M; Tokushige K; Shiratori K
J Gastroenterol; 2004 Dec; 39(12):1215-8. PubMed ID: 15622489
[TBL] [Abstract][Full Text] [Related]
19. [Relationship between morphological diagnosis of NASH (non-alcoholic steatohepatitis) and liver function tests in a group of patients with morbid obesity].
Chavarría-Arciniega S; López-Alvarenga JC; Uribe-Uribe NO; Herrera-Hernández M; González-Barranco J
Rev Invest Clin; 2005; 57(4):505-12. PubMed ID: 16315634
[TBL] [Abstract][Full Text] [Related]
20. Long-term efficacy of leptin replacement in patients with generalized lipodystrophy.
Javor ED; Cochran EK; Musso C; Young JR; Depaoli AM; Gorden P
Diabetes; 2005 Jul; 54(7):1994-2002. PubMed ID: 15983199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
